MTOX Financial Facts
Clinical trial services: 2.15MBasic (in shares): 8.9M
See Full Income Statement
Accumulated deficit: -12.72M
Total accounts receivable: 20.45M
See Full Balance Sheet
MEDTOX Scientific (MTOX) Earnings
|
Expand Research on MTOX
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -5.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -0.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7/11/12 | Q212 | $0.14 | $0.21 | -$0.07 | $30M | $30.28M | N/A |  | | Details | |
10/13/11  |
 |
Q311 | $0.15 | $0.17 | -$0.02 | $27.6M | $28.58M | N/A | | | Details |
| 7/14/11 |
|
Q211 | $0.16 | $0.18 | -$0.02 | $27.9M | $28.12M | N/A | | | Details |
| 2/9/12 |
|
Q411 | $0.11 | $0.12 | -$0.01 | $26.9M | $26.88M | N/A | | | Details |
| 2/10/11 |
|
Q410 | $0.09 | $0.09 | $0.00 | $25M | $24.49M | N/A | | | Details |
| 10/13/10 | Q310 | $0.13 | $0.13 | $0.00 | N/A | N/A | N/A | | | Details | |
| 4/14/11 |
|
Q111 | $0.09 | $0.08 | +$0.01 | $25.7M | $24.5M | N/A | | | Details |
| 4/12/12 |
|
Q112 | $0.17 | $0.13 | +$0.04 | $28.6M | $27.42M | N/A | | | Details |
